ANIL RAI: Open Payments
NPI 1306830658 · KINGSTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 13 payments from 7 companies in 2025. Trend: 2023 $391 · 2024 $989 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $227 |
| Alkermes, Inc. | 1 | $115 |
| Teva Pharmaceuticals USA, Inc. | 3 | $94 |
| Janssen Pharmaceuticals, Inc | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $22 |
| Lundbeck LLC | 1 | $16 |
Products named: COBENFY, ARISTADA, UZEDY, INVEGA SUSTENNA, SPRAVATO, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE, REXULTI.
Industry payments across PA — which companies pay providers there.
